Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

In the present study, we aimed to compare the clinical outcome of autogeneic and allogeneic natural killer (NK) cells immunotherapy for the treatment of recurrent breast cancer. Between July 2016 and February 2017, 36 patients who met the enrollment criteria were randomly assigned to two groups: aut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Liang, Shuzhen, Xu, Kecheng, Niu, Lizhi, Wang, Xiaohua, Liang, Yingqing, Zhang, Mingjie, Chen, Jibing, Lin, Mao
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584889/
https://ncbi.nlm.nih.gov/pubmed/28894383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S139986
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars